Showing results (231-240 of 406) with videos related to
Sort By:
Pageof 41
Cancer Research|November 15, 1995
In vivo antitumor effects of unconjugated CD30 monoclonal antibodies on human anaplastic large-cell lymphoma xenograftsZ G Tian, D L Longo, S Funakoshi, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 7, 2001
Autoreactive B cells escape clonal deletion by expressing multiple antigen receptorsJ J Kenny, L J Rezanka, A Lustig, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1991
p34cdc2 is physically associated with and phosphorylated by a cdc2-specific tyrosine kinaseD K Ferris, G A White, D J Kelvin, et al.Blood|July 1, 1994
Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptorK Hestdal, F W Ruscetti, R Chizzonite, et al.Biochemical and Biophysical Research Communications|May 19, 1997
Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinaseM R Smith, M L Wilson, R Hamanaka, et al.Annals of Internal Medicine|March 1, 1987
NIH conference. Immunomodulators in clinical medicineA S Fauci, S A Rosenberg, S A Sherwin, et al.Analytical Biochemistry|February 15, 1987
Generation of a murine monoclonal antibody that detects the fos oncogene productS L Giardina, S W Evans, L Gandino, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|September 1, 1996
A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinomaR G Fenton, R G Steis, K Madara, et al.Cancer|May 15, 1990
Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapyK C Conlon, W J Urba, J W Smith, et al.Cancer Research|September 1, 1985
Lymph node pathology of HTLV and HTLV-associated neoplasmsE S Jaffe, J Clark, R Steis, et al.Pageof 41